When recreational marijuana stores first opened their doors in the US state of Colorado on January 1, opponents predicted dire consequences: an influx of drug traffickers, a spike in fatal car accidents, and more crime. For their part, supporters claimed that legal weed could raise millions of dollars in tax revenue. Six months later, what have the results been? (See also: Six months after legalizing marijuana, two big things have happened in Colorado)
The Community Anti-Drug Coalition of America (CADCA), one of the largest anti-legalization organizations in the US has a curious sponsor: Purdue Pharma, the manufacturer of Oxy-Contin, the highly addictive painkiller that has been linked to thousands of overdose deaths nationwide. A familiar confederation of anti-pot interests have a financial stake in the status quo, including law enforcement agencies, pharmaceutical firms, and nonprofits funded by federal drug-prevention grants.
Only six months old, Colorado's recreational marijuana industry starts a transformation that could add hundreds of new pot businesses to the state and reconfigure the market's architecture. Previously, only owners of existing medical marijuana shops could apply to open recreational stores, and all businesses had to be generalists, growing the pot that they sold. Now, newcomers to the industry can apply for recreational marijuana business licenses. When these new businesses begin opening in October, all recreational marijuana companies will be allowed to specialize — for instance as stand-alone stores that don't grow their supply.
The Liquor Control Board has been warning of shortages when the first stores open in Washington state. The board plans to issue the first 15 to 20 retail licenses July 7, with shops allowed to open the next day. It’s not clear how many stores that will be. Board staff said at a meeting last week that just one store in Seattle is ready for its final inspection. Only 79 of the more than 2,600 people who applied for marijuana-growing licenses last fall have been approved as growers, and many of them aren’t ready to harvest. (See also: Everything you want to know about legal pot in Washington)
Latin America is now at the vanguard of international efforts to promote drug policy reform: Bolivia has rewritten its constitution to recognize the right to use the coca leaf for traditional and legal purposes, Uruguay has become the first nation in the world to adopt a legal, regulated Cannabis market, and Colombia, Mexico, Guatemala, and Ecuador are openly critiquing the prevailing international drug control paradigm at the UN. And now with the United States itself relaxing its marijuana laws state by state, the U.S. prohibitionist drug war strategies are losing credibility in the region.
The extent to which the ongoing drug-control reforms across the Americas are pushing the boundaries of the global legal framework laid down in three UN drug-control conventions has become a delicate issue. The decriminalization of possession for personal use in several Latin American countries and the establishment of a supervised injection room in Vancouver, Canada have already triggered protracted legal disputes with the International Narcotics Control Board (INCB), the quasi-judicial organ for the conventions’ implementation.
William Brownfield, assistant secretary at the US Bureau of International Narcotics and Law Enforcement Affairs, has charged that Jamaica and other Caribbean Community (CARICOM) member states that are moving to change marijuana laws did not consult the US government. He had informal talks with some CARICOM states but said those discussions were "not structured as formal dialogue between governments or between international partners". He also revealed that the US had developed four basic principles to address the issues surrounding the growing move to legalise marijuana. (See also: No need to consult US on ganja, says Knight)
The US Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification. "FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration," FDA Press Officer Jeff Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule." (See also: Scheduling in the international drug control system)
Evan Cox used to deliver pizza. But 18 months ago, as he was running out of money at college in Seattle, he had a new business idea. The state of Washington was in the process of legalising the sale of marijuana, but he guessed it would take time for pot shops to open. So he set up Winterlife, a marijuana-delivery service. Dope-delivery services are also popular in states with stricter laws. More than a dozen illegal delivery services now serve tokers in Manhattan and Brooklyn.
A recent neuroscience study from Harvard Medical School claims to have discovered brain differences between people who smoke marijuana and people who do not. Such well-intentioned and seemingly objective science is actually a new chapter in a politicized and bigoted history of drug science in the United States. Different-looking brains tell us literally nothing about who these people are, what their lives are like, why they do or do not use marijuana, or what effects marijuana has had on them.
Peña Nieto no tiene problema en extenderse y mostrarse debidamente contundente es cuando la conversación discurre por el pantanoso asunto de las drogas, sus mercados y sus clientes, de los que México se ha considerado tradicionalmente una víctima. La legalización de la marihuana en algunos Estados de EE UU, le digo al presidente, ¿no le complica el discurso tanto a usted como al presidente Obama en la lucha contra el narcotráfico?
Mexico and the United States cannot pursue diverging policies on marijuana legalization, Mexican President Enrique Pena Nieto was quoted as saying, hinting he may be open to following the lead taken by some U.S. states in changing drug laws. Political pressure has grown in Mexico to take a more liberal stance on marijuana. In an interview with Spanish newspaper El Pais, Pena Nieto said "we can't continue on this road of inconsistency between the legalization we've had [...] in the most important consumer market, the United States, and in Mexico where we continue to criminalize production of marijuana."
Weed is legal in at least some form in 22 states and the District of Columbia. Most allow it for medical use only. Colorado and Washington this year enacted laws that allow recreational use by adults. But more than two dozen states are considering new or expanded marijuana reform legislation, including complete legalization for adults, medical marijuana, hemp use and decriminalization. Which are the next five states likely to legalize marijuana?